KATHLEEN BARONE: Open Payments
NPI 1053327247 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,633 in 78 payments from 23 companies in 2025. Trend: 2023 $1,289 · 2024 $1,686 · 2025 $1,633
Food & beverage: $1,633
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $193 |
| ABBVIE INC. | 8 | $172 |
| AstraZeneca Pharmaceuticals LP | 5 | $155 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $153 |
| Exact Sciences Corporation | 8 | $151 |
| ALK-Abello, Inc | 5 | $107 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| PFIZER INC. | 4 | $77 |
| Astellas Pharma US Inc | 2 | $55 |
| Lilly USA, LLC | 3 | $55 |
Products named: XIFAXAN, VRAYLAR, Odactra, BREZTRI, The Cologuard Plus Collection Kit, REXULTI, Ozempic, Wegovy.
Industry payments across NY — which companies pay providers there.
